Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Paul Steven M, Chairman & CEO. Officer active across 5 companies, notably Karuna Therapeutics, Inc.. Cumulatively, 11 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €697k. Activity tracked since 17 August 2021. The latest transaction was filed on 12 September 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
PAUL STEVEN M is Président-Directeur Général and is reported as a director of Karuna Therapeutics, Inc., Sage Therapeutics, Inc., Rapport Therapeutics, Inc. and ALNYLAM PHARMACEUTICALS, INC., as well as President and CEO of Voyager Therapeutics, Inc. He has 11 filings in total, and across the sampled recent filings, buys amount to EUR 697223 and sells to EUR 620423, over the period from 2016-01-15 to 2025-09-15.